If the researchers have a suspicion that the new intervention is working far better than the control (trial being extended), don't they have a moral obligation to shut the trial down now and give the patients on the control drug the opportunity to have the new intervention? Does anyone know?
If the researchers have a suspicion that the new intervention is...
Add to My Watchlist
What is My Watchlist?